Skip to main content
. 2024 Dec 16;15:1447511. doi: 10.3389/fphar.2024.1447511

TABLE 2.

Drug concentrations and clearance results.

Drug Infusion rate (mg/h) Added drug (mg) Eliminated drug (mg/9 h) Drug removal (%) CLADVOS [L/h] CLCRRT [L/h]
BFR 100 mL/min CFR 160 mL/min DFR 800 mL/min BFR 200 mL/min CFR 320 mL/min DFR 800 mL/min BFR 200 mL/h DFR 2 L/h
Anidulafungin 5.1 63 38 61 0.84 0.84 0.02
Cefotaxime 74.9 849 787 93 2.74 4.77 1.34
Daptomycin 74 1,004 787 78 1.04 1.36 0.10
Fluconazole 56 576 540 94 3.39 6.20 1.80
Ganciclovir 23.7 262 246 94 2.91 5.88 1.98
Linezolid 26.8 281 258 92 2.79 4.65 1.38
Meropenem 59.2 595 556 93 3.40 6.08 1.96
Piperacillin 164 1784 1,667 93 3.18 5.61 1.56

Residual CL (renal + non-renal) is neglected for calculation purposes. CRRT, clearance was calculated assuming a dialysate flow rate of 2 L/h. BFR: blood flow rate; CFR: concentrate flow rate; CL: clearance; CRRT: continuous renal replacement therapy; DFR: dialysate flow rate; grey shaded rows indicate drug with protein binding >90%.